SG Americas Securities
AVXL icon

SG Americas Securities’s Anavex Life Sciences AVXL Stock Holding History

SG Americas Securities’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,927
Closed -$67K – 3220
2025
Q4 		$67K Buy
18,927
+7,987
+73% +$48.9K ﹤0.01% 3312
2025
Q3 		$97K Buy
+10,940
New +$111K ﹤0.01% 3092
2025
Q2 		– Sell
-25,242
Closed -$217K – 2939
2025
Q1 		$217K Sell
25,242
-9,602
-28% -$90.7K ﹤0.01% 2475
2024
Q4 		$374K Buy
34,844
+7,138
+26% +$54.9K ﹤0.01% 1604
2024
Q3 		$157K Buy
27,706
+14,272
+106% +$82.3K ﹤0.01% 2679
2024
Q2 		$57K Buy
+13,434
New +$54.3K ﹤0.01% 2654
2024
Q1 		– Sell
-307,568
Closed -$2.86M – 2972
2023
Q4 		$2.86M Buy
307,568
+38,155
+14% +$263K 0.03% 528
2023
Q3 		$1.76M Buy
+269,413
New +$2.14M 0.02% 825
2023
Q2 		– Sell
-31,382
Closed -$269K – 2310
2023
Q1 		$269K Buy
31,382
+14,309
+84% +$143K ﹤0.01% 2198
2022
Q4 		$158K Buy
17,073
+2,615
+18% +$27.9K ﹤0.01% 2381
2022
Q3 		$149K Sell
14,458
-19,036
-57% -$201K ﹤0.01% 2552
2022
Q2 		$335K Buy
+33,494
New +$317K ﹤0.01% 2307
2022
Q1 		– Sell
-12,550
Closed -$218K – 2964
2021
Q4 		$218K Sell
12,550
-12,656
-50% -$240K ﹤0.01% 2627
2021
Q3 		$452K Buy
+25,206
New +$502K ﹤0.01% 2596
2021
Q2 		– Sell
-10,419
Closed -$156K – 2854
2021
Q1 		$156K Buy
+10,419
New +$114K ﹤0.01% 2833
2018
Q1 		– Sell
-21,389
Closed -$69K – 3232
2017
Q4 		$69K Buy
+21,389
New +$84.2K ﹤0.01% 2928
2016
Q2 		– Sell
-12,700
Closed -$62K – 2595
2016
Q1 		$62K Buy
+12,700
New +$55.9K ﹤0.01% 2736

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SG Americas Securities's AVXL Position: Q1 2026 in Review

SG Americas Securities sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 18,927 shares — an estimated $67K sold.

SG Americas Securities first reported a position in AVXL in Q1 2016 and held it in 17 quarters. The position peaked at $2.86M in Q4 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • SG Americas Securities reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 18,927 Anavex Life Sciences shares in Q1 2026, an estimated $67K.
  • SG Americas Securities first reported a position in Anavex Life Sciences in Q1 2016 and held it in 17 quarters.
  • SG Americas Securities's Anavex Life Sciences position peaked at $2.86M in Q4 2023.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.